PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application

Biodegradable microspheres have been widely used in the field of medicine due to their ability to deliver drug molecules of various properties through multiple pathways and their advantages of low dose and low side effects. Poly (lactic-co-glycolic acid) copolymer (PLGA) is one of the most widely us...

Full description

Saved in:
Bibliographic Details
Published inDrug delivery Vol. 28; no. 1; pp. 1397 - 1418
Main Authors Su, Yue, Zhang, Bolun, Sun, Ruowei, Liu, Wenfang, Zhu, Qubo, Zhang, Xun, Wang, Rongrong, Chen, Chuanpin
Format Journal Article
LanguageEnglish
Published Philadelphia Taylor & Francis 01.01.2021
Taylor & Francis Ltd
Taylor & Francis Group
Subjects
Online AccessGet full text
ISSN1071-7544
1521-0464
1521-0464
DOI10.1080/10717544.2021.1938756

Cover

More Information
Summary:Biodegradable microspheres have been widely used in the field of medicine due to their ability to deliver drug molecules of various properties through multiple pathways and their advantages of low dose and low side effects. Poly (lactic-co-glycolic acid) copolymer (PLGA) is one of the most widely used biodegradable material currently and has good biocompatibility. In application, PLGA with a specific monomer ratio (lactic acid and glycolic acid) can be selected according to the properties of drug molecules and the requirements of the drug release rate. PLGA-based biodegradable microspheres have been studied in the field of drug delivery, including the delivery of various anticancer drugs, protein or peptide drugs, bacterial or viral DNA, etc. This review describes the basic knowledge and current situation of PLGA biodegradable microspheres and discusses the selection of PLGA polymer materials. Then, the preparation methods of PLGA microspheres are introduced, including emulsification, microfluidic technology, electrospray, and spray drying. Finally, this review summarizes the application of PLGA microspheres in drug delivery and the treatment of pulmonary and ocular-related diseases.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:1071-7544
1521-0464
1521-0464
DOI:10.1080/10717544.2021.1938756